There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...

Biologic response modifiers ... Aggressive early use of disease-modifying antirheumatic drugs (DMARDs) is indicated for patients with rheumatoid arthritis (RA) to prevent joint damage and improve ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA).

Eberhard and colleagues noted that "only limited results are available from observational studies comparing the effectiveness ...

The efficacy is said to be equal or slightly better than biological agents ... there has been great advancements in treating rheumatoid arthritis.

Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...